She's particularly advocated for the further studies of ibogaine, which is derived from a Central African plant called iboga. Veterans treated out …
She's particularly advocated for the further studies of ibogaine, which is derived from a Central African plant called iboga. Veterans treated out …
Privately-held Gilgamesh Pharmaceuticals has reported immense success treating depression with its novel psychedelic compound.
On Tuesday, the company dropped data from a Phase 2a study showing that nearly all trial participants suffering from the mental health condition went into remission post-adminstration. Specifically, 70 per cent reported immense alleviation from their major depressive disorder (MDD) within two weeks and 94 per cent went into remission within 30 days.
GM-2505 gets administered via intravenous infusion with ...
Others have raised questions about the lack of recognition of traditional knowledge holders and those who have been stewarding the shrub, and its use, for many years.
One such voice is Dr. Joseph Barsuglia who, along with his wife Tricia Eastman, has extensive experience with ibogaine, including running and advising clinics and retreats, studying with Bwiti elders in Gabon, fundraising for iboga preservation, and advising ibogaine efforts in four U.S. states. He’s also involved ...
Let’s be honest – there is a disconnect in ibogaine research. On one side, we have promising clinical studies showing ibogaine’s potential for treating opioid use disorder, PTSD, and traumatic brain injury. On the other, we have approximately 10,000 people who have actually undergone ibogaine treatment, many traveling internationally to access it. Their experiences hold invaluable insights that traditional clinical trials might miss.
As someone who has published extensively on ibogaine’s clinical applications (Alan), ...
… ibogaine, a compound derived from the West African iboga plant that has been used in other countries…